Treating children with tuberculosis: new weapons for an old enemy
Tommaso Matucci1, Luisa Galli1, Maurizio de Martino1
1Department of Health Sciences, Anna Meyer Children University Hospital, University of Florence , Florence , Italy.
Insights
Pediatric tuberculosis treatment differs significantly from adult care, necessitating tailored approaches for drug-susceptible, drug-resistant, and extrapulmonary tuberculosis in children to improve outcomes and safety.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) is a global health crisis impacting millions worldwide.
- Pediatric TB has been historically underserved, requiring specialized management strategies.
- Effective TB control necessitates addressing unique challenges in children.
Purpose of the Study:
- To highlight critical differences in TB treatment between children and adults.
- To analyze the impact of these differences on treatment outcomes, safety, and tolerability.
- To advocate for a more child-centered approach to pediatric TB management.
Main Methods:
- Comparative analysis of adult and pediatric TB treatment guidelines.
- Review of existing literature on pediatric TB pharmacotherapy and clinical management.
- Examination of safety and tolerability data for anti-TB drugs in pediatric populations.
Main Results:
- Pediatric TB treatment presents unique pharmacokinetic and pharmacodynamic challenges.
- Dosage adjustments and formulation development are crucial for effective pediatric TB therapy.
- Extrapulmonary and drug-resistant TB in children require distinct management protocols compared to adults.
Conclusions:
- Current TB treatment paradigms require significant adaptation for pediatric populations.
- A child-oriented approach is essential for optimizing treatment efficacy and minimizing adverse events in pediatric TB.
- Further research is needed to refine pediatric TB treatment strategies and improve global health outcomes.
Abstract:
Tuberculosis has risen to worldwide attention due to its widespread diffusion and overall impact on health and life expectancy. Despite being historically neglected, children require a different approach and management from adults. From the treatment of drug-susceptible pulmonary tuberculosis to extensively drug-resistant strains, and extrapulmonary disease, therapies in children require revision and a more children-oriented approach. We therefore exposed the main critical points and differences between treatment in adults and children and the possible consequences on outcome, safety and tolerability.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Drug Dosing: Infants and Children